t(4;14)易位断裂点在NSD2基因内的位置可识别高危新诊断多发性骨髓瘤患者亚群
研究对258例t(4;14)新诊断多发性骨髓瘤(NDMM)患者(发现集153例、复制集105例)及183例非t(4;14)患者行全基因组测序与转录组测序并结合临床数据分析。结果显示NSD2基因内断裂点位置不同,总生存期存在显著差异,且该结果在独立复制集中得到验证;del17p、1p异常独立导致t(4;14)患者预后不良。
要点
- 仅约25%的t(4;14)患者总生存期不足24个月,提示该亚群内部预后差异明显。
- 按断裂点位置分组,中位总生存期:late-disruption 28.6个月、early-disruption 59.2个月、no-disruption 75.1个月。
- 单因素与多因素分析提示del17p、1p异常独立导致t(4;14)多发性骨髓瘤患者预后不良。
核心结论
- t(4;14)易位断裂点在NSD2基因内的位置及IgH-NSD2融合转录本的表达,与t(4;14)新诊断多发性骨髓瘤患者的不良预后相关,并识别出一个高危亚群。
研究设计与样本
- 研究对258例t(4;14)新诊断多发性骨髓瘤患者(发现集153例、复制集105例)及183例非t(4;14)患者行全基因组测序与转录组(RNA测序)分析,并纳入相关临床数据。
主要发现
- 标志性生存分析显示仅约25%的t(4;14)患者总生存期小于24个月。
- 按NSD2基因内断裂点位置分组,中位总生存期:late-disruption组28.6个月,early-disruption组59.2个月,no-disruption组75.1个月,组间差异显著。
- 上述结果在独立复制数据集中得到重复。
- 单因素与多因素分析提示del17p、1p异常独立导致t(4;14)多发性骨髓瘤患者预后不良。
关键数值与推荐
- 断裂点分为三类:no-disruption(位于NSD2上游)、early-disruption(位于5' UTR内)、late-disruption(位于NSD2基因内)。
- 中位总生存期:late-disruption组28.6个月,early-disruption组59.2个月,no-disruption组75.1个月。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Although translocation events between chromosome 4 (NSD2 gene) and chromosome 14 (immunoglobulin heavy chain [IgH] locus) (t(4;14)) is considered high risk in newly diagnosed multiple myeloma (NDMM), only ∼30% to 40% of t(4;14) patients are clinically high risk. We generated and compared a large whole genome sequencing (WGS) and transcriptome (RNA sequencing) from 258 t(4;14) (n = 153 discovery, n = 105 replication) and 183 non-t(4;14) NDMM patients with associated clinical data. A landmark survival analysis indicated only ∼25% of t(4;14) patients had an overall survival (OS) <24 months, and a comparative analysis of the patient subgroups identified biomarkers associated with this poor outcome, including translocation breakpoints located in the NSD2 gene and expression of IgH-NSD2 fusion transcripts. Three breakpoints were identified and are designated as: "no-disruption" (upstream of NSD2), "early-disruption" (in the 5' UTR), and "late-disruption" (within the NSD2 gene). Our results show a significant difference in OS based on the location of DNA breakpoints (median OS 28.6 "late-disruption" vs 59.2 "early disruption" vs 75.1 months "no disruption"). These findings have been replicated in an independent replication dataset. Also, univariate and multivariate analysis suggest high-risk markers such as del17p, 1p independently contribute to poor outcome in t(4;14) MM patients.
引用
- Stong N, Ortiz-Estévez M, Towfic F, et al. The location of the t(4;14) translocation breakpoint within the NSD2 gene identifies a subset of patients with high-risk NDMM. Blood. 2023. PMID: 35984902. doi:10.1182/blood.2022016212
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。